The effect of Melissa officinalis syrup on patients with mild to moderate psoriasis: a randomized, double-blind placebo-controlled clinical trial.

Citation metadata

From: BMC Research Notes(Vol. 14, Issue 1)
Publisher: BioMed Central Ltd.
Document Type: Report
Length: 2,932 words
Lexile Measure: 1410L

Document controls

Main content

Abstract :

Objective Psoriasis is an immune-mediated inflammatory skin disease. It can involve any body skin area, particularly the scalp, lower back, elbows, and knees. There are several topical and systemic therapies for the treatment. Nowadays, herbal medicines are popular treatments for dermatologic conditions. This two-arm parallel, randomized placebo-controlled clinical trial was conducted to examine the hypothesis of the efficacy of Melissa officinalis syrup on patients with mild-to-moderate Plaque psoriasis. Result Among 100 patients, 95 participants completed the trial and five of them withdrew. The mean pruritus intensity and PASI scores decreased significantly in the intervention group compared to the placebo group (P Trial registration: The trial was registered in the Iranian registry of clinical trials on November 9th, 2019 (; registration number: IRCT20191104045326N1). Keywords: Psoriasis, Quality of life, Pruritus, Melissa officinalis syrup

Source Citation

Source Citation   

Gale Document Number: GALE|A672312803